Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator

Bibliographic Details
Main Authors:	Steven H Back, Peter R Kowey
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2019-01-01
Series:	Arrhythmia & Electrophysiology Review
Online Access:	https://www.aerjournal.com/articles/Shocks-Ventricular-Arrhythmias-In-Patients-With-ICD

Similar Items

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
by: Hans Römers, MSc, et al.
Published: (2023-01-01)

Malignant ventricular arrhythmias in patients with implantable cardioverter-defibrillators: electrical signals which are predictors of recurrence
by: Ailema A. Alemán-Fernández, et al.
Published: (2017-02-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators
by: Hao Huang, et al.
Published: (2022-05-01)

Impact of Myocardial Bridge on Life‐Threatening Ventricular Arrhythmia in Patients With Implantable Cardioverter Defibrillator
by: Kozo Okada, et al.
Published: (2020-11-01)

Ventricular arrhythmias among patients with implantable cardioverter‐defibrillator during the COVID‐19 pandemic
by: G. Malanchini, et al.
Published: (2021-04-01)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
by: Anne‐Lotte C.J. van derLingen, et al.
Published: (2021-10-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.
by: Parkes, et al.
Published: (2000-01-01)

Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients
by: You Zhou, et al.
Published: (2019-05-01)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
by: Alwin B. P. Noordman, et al.
Published: (2021-08-01)

Case report: Implantable cardioverter-defibrillator implantation with optimal medical treatment for lethal ventricular arrhythmia caused by recurrent coronary artery spasm due to tyrosine kinase inhibitors
by: Jifu Jin, et al.
Published: (2023-03-01)

Implantable Cardioverter Defibrillator
by: Dicky Armen Hanafy
Published: (2013-07-01)

The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot
by: Satoshi Kawada, MD, PhD, et al.
Published: (2021-05-01)

Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillatorResearch in context
by: Maarten Z.H. Kolk, et al.
Published: (2024-01-01)

Main air pollutants and ventricular arrhythmias in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis
by: Hong-Jie Yang, et al.
Published: (2017-12-01)

Molecular mechanisms of heart failure progression associated with implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias
by: Yukiomi Tsuji, MD, PhD, et al.
Published: (2014-08-01)

Genome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmias.
by: Sarah S Murray, et al.
Published: (2012-01-01)

Thoracoscopic Left Cardiac Sympathetic Denervation for a Patient with Catecholaminergic Polymorphic Ventricular Tachycardia and Recurrent Implantable Cardioverter-Defibrillator Shocks
by: Woo-Sik Yu, et al.
Published: (2015-06-01)

Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
by: Selçuk Adabag, et al.
Published: (2021-06-01)

Implantable cardioverter-defibrillator failure unmasked by a “lucky” shock
by: Lim K. Eng, et al.
Published: (2012-08-01)

The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
by: Özge Çakmak Karaaslan, et al.
Published: (2023-01-01)

Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients with Ventricular Arrhythmia of Unclear Cause in Secondary Prevention of Sudden Cardiac Death
by: Alwin B. P. Noordman, et al.
Published: (2023-07-01)

Incidence of Ventricular Arrhythmias and 1‐Year Predictors of Mortality in Patients Treated With Implantable Cardioverter‐Defibrillator Undergoing Generator Replacement
by: Andrea Demarchi, et al.
Published: (2021-02-01)

Primary Prevention of Fatal Ventricular Arrhythmias With Implantable Cardioverter- Defibrillator Therapy – An Analysis of Implications Based on MADIT II Criteria
by: Zia I Carrim, et al.
Published: (2020-12-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
by: Xuerong Sun, et al.
Published: (2021-09-01)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
by: Valentino Ducceschi, et al.
Published: (2022-06-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

Recurrent episodes of ventricular tachycardia in a patient with Brugada syndrome was converted by implantable cardioverter defibrillator (ICD)
by: Milanov Zoran, et al.
Published: (2015-01-01)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Automatic implantable cardioverter defibrillator: when not to implant
by: Maria Teresa La Rovere, et al.
Published: (2020-02-01)

Misinterpretation of dual atrioventricular nodal non-reentrant tachycardia as ventricular tachycardia and implantation of implantable cardioverter-defibrillator followed by inappropriate shocks
by: Yusuf Türkmen
Published: (2020-07-01)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation
by: Banveet Kaur Khetarpal, et al.
Published: (2023-04-01)

Externalized biventricular implantable cardioverter-defibrillator
by: Sofia Lázaro Mendes, et al.
Published: (2016-04-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

In response to, ′Magnets and implantable cardioverter defibrillators′
by: Somsri Wiwanitkit, et al.
Published: (2013-01-01)

An unusual cause of recurrent syncope in a patient with implantable cardioverter defibrillator
by: Armando Gardini, et al.
Published: (2015-07-01)